|
|
| Home | Stock Market Blogs | Financial Tools | Sign Up Free | |
| Brainstorm Cell Therapeutics, Inc. | |
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Brainstorm Cell Therapeutics, Inc. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BCLI | Last: $0.19 ($-0.01) | Volume: 130,871 | Last Trade: 8/5/2010 5:20:02 PM | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Today
Today | Last 7 Days | 1 Month | 3 Month | 6 Month | 1 Year |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Brainstorm Cell Therapeutics, Inc. Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Brainstorm Cell Therapeutics, Inc. develops NurOwn cell therapy products sourced from adult stem cells for treatment of neurodegenerative diseases. It primarily focuses on the development of bone marrow derived neural-like cells for Parkinson's disease. Brainstorm Cell Therapeutics is also developing embryonic stem cells and adult stem cells for multiple cell therapy products. The company was incorporated in 2000 under the name Wizbang Technologies, Inc. and changed its name to Golden Hand Resources, Inc. in 2003. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Brainstorm Cell Therapeutics, Inc. News & Press Releases | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|
BrainStorm To Present At World Stem Cells and Regenerative Medicine Congress BrainStorm Cell Therapeutics Inc. ( BCLI ), a leading developer of adult stem cell technologies and therapeutics is pleased to announce that Dr. Avinoam Kadour... [more] World Renowned ALS Expert From Harvard Medical School and Mass. General Hospital, Dr. Robert H. Brow Brainstorm Cell Therapeutics Inc. ( BCLI ), a leading developer of adult stem cell technologies and therapeutics, announced today that world renowned ALS medic... [more] BrainStorm Cell Therapeutics NTF Cells Shows Significant Advantage in Pre-Clinical Study for Parkins BrainStorm Cell Therapeutics Inc. ( BCLI ), a leading developer of adult stem cell technologies and therapeutics, announced today that in a pre-clinical study... [more] Brainstorm Cell Therapeutics Chief Scientist, Dr. Daniel Offen, To Present Results from New Parkinso BrainStorm Cell Therapeutics Inc. ( BCLI ), a leading developer of adult stem cell technologies and therapeutics, announced today that Dr. Daniel Offen, the Co... [more] |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | Blogs | Savings Calculator | Tools | Contact Us | Disclosure | Site Map | Sign Up | Copyright © 2013 SmallCapWatch, LLC. |
| Never invest based soley on information from this website or our e-mail and IM alerts | |
